20/20 BIOLABS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
20/20 BIOLABS, INC. (AIDX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 602.94 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- 20/20 BIOLABS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 250.00K shares.
- 20/20 BIOLABS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 352.94K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|
| 2026-06-30 | 250.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 602.94K shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 352.94K shares 10-Q · filed 2026-05-20 | ||
| 2024-12-31 | 765.00K shares POS AM · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |